# FDA Warning Letter: MB Solutions, LLC/BioSpectrum CBD
> 2021-07-29 · Center for Drug Evaluation and Research · `f9c3d6a8678f69ac`
## Letter
- **Company:** MB Solutions, LLC/BioSpectrum CBD
- **Posted Date:** 2021-07-29
- **Letter Issue Date:** 2021-07-22
- **Issuing Office:** Center for Drug Evaluation and Research
## Subject
Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*